Startups
BRAND CORNERSTONES
• Strong scientific / technical capabilities
• Exceptional people
• 360º Quality
• Extensive manufacturing capacity
• Rigorous project management
• Focused expertise in key areas
• Strong scientific / technical capabilities
• Exceptional people
• 360º Quality
• Extensive manufacturing capacity
• Rigorous project management
• Focused expertise in key areas
Overview
Location
United States, New Jersey
Employees
1001-5000
Phone
+351 21 982 9000
Founded date
1959
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 28, 2025 | Hovione: $100 Million Expansion Of New Jersey Manufacturing Site Completed | Hovione, a global contract development and manufacturing organization (CDMO), announced the completion of its initial $100 million investment cycle to expand its New Jersey manufacturing site, marking a significant step in the company’s lon... |
| Mar 20, 2023 | Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space | LISBON, Portugal, March 20, 2023 /PRNewswire/ -- Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and Ripple Therapeutics, a leading ophthalmic sustained drug delivery company, have entered a strateg... |
| Mar 8, 2023 | Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise | LISBON, Portugal, March 8, 2023 /PRNewswire/ -- Hovione, the leader in spray drying and particle engineering, won the 2023 CDMO Leadership Award across all six categories – capability, compatibility, expertise, quality, reliability and serv... |
| Dec 14, 2022 | Hovione and GEA announce a strategic collaboration to advance Continuous Tableting | LISBON, Portugal, Dec. 14, 2022 /PRNewswire/ -- Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years. It ... |
| Aug 23, 2022 | Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals | Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals Tue, Aug 23, 2022 11:00 CET Report this content AUGUST 23, 2022 (COPENHAGEN, Denmark). Zerion Pharma A/S (ZERION) and Hovione... |
| Aug 23, 2022 | Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals | LISBON, Portugal, Aug. 23, 2022 /PRNewswire/ -- Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary sup... |
| Feb 25, 2022 | Jean-Luc Herbeaux to become Hovione CEO | LISBON, Portugal, Feb. 25, 2022 /PRNewswire/ -- Hovione today announced that the Board of Directors and the shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione's Chief Executive Officer, effective 1st April 2022. ... |
| Feb 22, 2022 | Zerion Pharma and Hovione form strategic partnership to market and commercialise the proprietary Dispersome® technology platform | Zerion Pharma and Hovione form strategic partnership to market and commercialise the proprietary Dispersome® technology platform Tue, Feb 22, 2022 15:00 CET Report this content February 22, 2022 (COPENHAGEN, Denmark). Zerion Pharma A/S (ZER... |
| Mar 17, 2021 | Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction | CORK, Ireland, March 17, 2021 /PRNewswire/ -- Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its Phase 2 clinical trial in 270 patients with Dry Eye caused by Meibomian Gland Dys... |
Reviews 0
FAQ about Hovione
When was Hovione founded?
Hovione was founded in 1959.
What has the press written about Hovione?
Parsers VC has collected 10 articles mentioning Hovione, among them “Hovione: $100 Million Expansion Of New Jersey Manufacturing Site Completed” (Oct 28, 2025) and “Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space” (Mar 20, 2023).
Is Hovione still active?
Yes, Hovione is active; its latest activity on Parsers VC dates from Sep 15, 2026.